Correlation of the C677T MTHFR genotype with homocysteine levels in children with sickle cell disease

被引:22
作者
Balasa, VV
Gruppo, RA
Gartside, PS
Kalinyak, KA
机构
[1] Childrens Hosp, Med Ctr, Div Hematol Oncol, Cincinnati, OH 45229 USA
[2] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA
关键词
enzyme methylenetetrahydrofolate reductase; homocysteine; sickle cell; children; stroke;
D O I
10.1097/00043426-199909000-00011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recently, a mild to moderate elevation in the plasma homocysteine (Hcy) level has been found to be an important risk factor for stroke. Homozygosity for a common mutation (C677T) in the gene encoding for the enzyme methylenetetrahydrofolate reductase (MTHFR) involved in Hcy metabolism has been associated with increased levels of Hey. To determine the role of hyperhomocysteinemia in the pathogenesis of stroke in children with sickle cell disease (SCD), Hey levels and C677T MTHFR genotype were determined in 40 patients homozygous for hemoglobin SS and compared with 197 healthy children. Eleven of 40 patients with SCD had a history of stroke. The prevalence of homozygosity for the C677T MTHFR variant was 5% in the patients with SCD. The median Hey level was 5.8 mu mol/L in the patients versus 5.4 mu mol/L in the controls (Fisher's, P > 0.05). There was no correlation of Hey levels with the MTHFR genotype in patients with SCD. In patients with SCD and stroke, the median Hey level was 4.8 mu mol/L versus 6.0 mu mol/L in those without stroke (P = 0.44, Mann-Whitney rank sum test). There was no difference in the proportion of patients with SCD with or without stroke who were homozygous for the C677T MTHFR mutation (0/11 versus 2/29; Fisher's, P = 1.000). In conclusion, this study failed to demonstrate an elevation in plasma Hey levels in children with SCD compared with normal controls. Furthermore, hyperhomocysteinemia did not seem to be a significant factor in the pathogenesis of stroke in children with SCD.
引用
收藏
页码:397 / 400
页数:4
相关论文
共 19 条
  • [1] PLASMA HOMOCYSTEINE BEFORE AND AFTER METHIONINE LOADING WITH REGARD TO AGE, GENDER, AND MENOPAUSAL STATUS
    ANDERSSON, A
    BRATTSTROM, L
    ISRAELSSON, B
    ISAKSSON, A
    HAMFELT, A
    HULTBERG, B
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1992, 22 (02) : 79 - 87
  • [2] The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults
    Balasa, VV
    Gruppo, RA
    Glueck, CJ
    Stroop, D
    Becker, A
    Pillow, A
    Wang, P
    [J]. THROMBOSIS AND HAEMOSTASIS, 1999, 81 (05) : 739 - 744
  • [3] ELEVATED PLASMA HOMOCYST(E)INE CONCENTRATION AS A POSSIBLE INDEPENDENT RISK FACTOR FOR STROKE
    COULL, BM
    MALINOW, MR
    BEAMER, N
    SEXTON, G
    NORDT, F
    DEGARMO, P
    [J]. STROKE, 1990, 21 (04) : 572 - 576
  • [4] A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE
    FROSST, P
    BLOM, HJ
    MILOS, R
    GOYETTE, P
    SHEPPARD, CA
    MATTHEWS, RG
    BOERS, GJH
    DENHEIJER, M
    KLUIJTMANS, LAJ
    VANDENHEUVEL, LP
    ROZEN, R
    [J]. NATURE GENETICS, 1995, 10 (01) : 111 - 113
  • [5] GRAY NT, 1992, AM J PEDIAT HEMATOL, V14, P57
  • [6] Homocysteine in sickle cell disease: Relationship to stroke
    Houston, PE
    Rana, S
    Sekhsaria, S
    Perlin, E
    Kim, KS
    Castro, OL
    [J]. AMERICAN JOURNAL OF MEDICINE, 1997, 103 (03) : 192 - 196
  • [7] Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations
    Jacques, PF
    Bostom, AG
    Williams, RR
    Ellison, RC
    Eckfeldt, JH
    Rosenberg, IH
    Selhub, J
    Rozen, R
    [J]. CIRCULATION, 1996, 93 (01) : 7 - 9
  • [8] KANG SS, 1991, AM J HUM GENET, V48, P536
  • [9] Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease
    Key, NS
    Slungaard, A
    Dandelet, L
    Nelson, SC
    Moertel, C
    Styles, LA
    Kuypers, FA
    Bach, RR
    [J]. BLOOD, 1998, 91 (11) : 4216 - 4223
  • [10] Khanduri U, 1998, THROMB HAEMOSTASIS, V79, P879